Search Results - raphael+schiffmann

2 Results

Sort By:

Bile Acids and Other Agents that Modulate the Gut Microbiome for the Treatment of Liver Cancer

Abstract: Primary liver tumors and secondary hepatic malignancies are among the leading causes of cancer-related deaths. Liver metastases account for 95% of all hepatic cancers, and the liver is the most common site for organ metastasis in the body. The gut microbiome serves an important role in antitumor immunity regulating the efficacy of chemo- and...

Published: 4/8/2024 | Inventor(s): Tim Greten, Chi Ma

Keywords(s): Bile Acid, Greten, Liver cancer, Natural Killer T Cells, NKT cells

Category(s): Collaboration Sought > Collaboration, TherapeuticArea > Oncology, Application > Therapeutics, Collaboration Sought > Licensing

Diagnosis and Prognosis of Fabry Disease by Detecting Neuronal Apoptosis Inhibitor Protein (NAIP) Expression

Fabry disease is a severe metabolic disorder that affects the vascular system of multiple tissues and organs. An estimated 1 in 40,000 individuals inherit this rare disease, and suffer from various complications including stroke, renal failure, and cardiac arrest. At present, molecular markers that directly measure cellular dysfunction to not exist,...

Published: 4/8/2024 | Inventor(s): Raphael Schiffmann

Keywords(s): AA5XXX, AAXXXX, AXXXXX, Fabry Disease, metabolic disorder

Category(s): Collaboration Sought > Licensing